Doctor profile · Federal record
Dr. Ronald Brancaccio
Specialist (CMS: Dermatology) · Brooklyn, NY
- NPI 1174578769
- Accepts Medicare
- MIPS 96.5 / 100 · 2023
- 54 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
7901 4Th Ave
Brooklyn, NY 112093957
(718) 491-5800
fax (718) 748-2151
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- August 14, 2012
- Year of graduation
- 1972 — 54 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- New York #122348-1
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1174578769. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
8,904
Distinct HCPCS
10
Medicare allowed
$443,208
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 3,000 | 13 | $2 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,329 | 303 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,249 | 853 | $106 | |
17000 |
Destruction of precancer skin growth, 1 growth | 711 | 495 | $69 | |
11102 |
Biopsy of related skin growth, first growth | 496 | 435 | $121 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 406 | 212 | $150 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 386 | 290 | $67 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 312 | 105 | $1 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 177 | 177 | $134 | |
11900 |
Injection into skin growth, 1-7 growths | 146 | 76 | $60 |
In context: peer comparison
Among 50 peers in Brooklyn Specialist, average services per provider: 234. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$1,481
Transactions
69
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 22 | $419.03 | |
| Dermavant Sciences, INC. | 12 | $216.65 | |
| Regeneron Healthcare Solutions, INC. | 6 | $155.30 | |
| Pfizer INC. | 7 | $143.33 | |
| Amgen INC. | 6 | $119.20 | |
| Janssen Biotech, INC. | 2 | $118.18 | |
| Arcutis Biotherapeutics, INC. | 4 | $82.11 | |
| Sun Pharmaceutical Industries INC. | 3 | $74.59 | |
| Genzyme Corporation | 3 | $72.64 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $26.58 | |
| Leo Pharma INC. | 1 | $18.32 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 1 | $18.01 | |
| Incyte Corporation | 1 | $16.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,384
Patients
869
Total drug cost
$175,528
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 299 | 179 | $7,584 |
| Triamcinolone Acetonide | Generic | 213 | 158 | $3,178 |
| Clobetasol Propionate | Generic | 150 | 70 | $11,400 |
| Betamethasone Dipropionate | Generic | 129 | 82 | $6,661 |
| Mupirocin | Generic | 111 | 82 | $1,068 |
| Clindamycin Phosphate | Generic | 83 | 37 | $3,262 |
| Mometasone Furoate | Generic | 81 | 54 | $1,667 |
| Doxycycline Hyclate | Generic | 63 | 44 | $1,309 |
| Fluocinonide | Generic | 47 | 38 | $2,490 |
| Metronidazole | Generic | 40 | 24 | $4,377 |
Frequently asked questions
What is Dr. Ronald Brancaccio's medical specialty?
Dr. Ronald Brancaccio practices Specialist in Brooklyn, NY.
Where does Dr. Ronald Brancaccio practice?
Dr. Ronald Brancaccio practices at 7901 4Th Ave, Brooklyn, NY 112093957. Office phone: 7184915800.
What is Dr. Ronald Brancaccio's NPI?
Dr. Ronald Brancaccio's National Provider Identifier (NPI) is 1174578769, issued by NPPES.
Does Dr. Ronald Brancaccio accept Medicare assignment?
Yes. Dr. Ronald Brancaccio accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ronald Brancaccio commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.